These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37651889)

  • 1. Surgical quality and prospective quality control of the D2-gastrectomy for gastric cancer in the multicenter randomized LOGICA-trial.
    de Jongh C; Triemstra L; van der Veen A; Brosens LA; Nieuwenhuijzen GA; Stoot JH; de Steur WO; Ruurda JP; van Hillegersberg R;
    Eur J Surg Oncol; 2023 Oct; 49(10):107018. PubMed ID: 37651889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distal Versus Total D2-Gastrectomy for Gastric Cancer: a Secondary Analysis of Surgical and Oncological Outcomes Including Quality of Life in the Multicenter Randomized LOGICA-Trial.
    de Jongh C; van der Veen A; Brosens LAA; Nieuwenhuijzen GAP; Stoot JHMB; Ruurda JP; van Hillegersberg R;
    J Gastrointest Surg; 2023 Sep; 27(9):1812-1824. PubMed ID: 37340107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of station-specific lymph node yield in laparoscopic and open distal gastrectomy for early gastric cancer.
    Bouras G; Lee SW; Nomura E; Tokuhara T; Tsunemi S; Tanigawa N
    Surg Laparosc Endosc Percutan Tech; 2011 Dec; 21(6):424-8. PubMed ID: 22146165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
    Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of lymph node metastases in gastric cancer: a side-study of the multicenter LOGICA-trial.
    de Jongh C; Triemstra L; van der Veen A; Brosens LAA; Luyer MDP; Stoot JHMB; Ruurda JP; van Hillegersberg R;
    Gastric Cancer; 2022 Nov; 25(6):1060-1072. PubMed ID: 36103060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery.
    Roukos DH; Paraschou P; Lorenz M
    Ann Surg Oncol; 2000 Dec; 7(10):719-26. PubMed ID: 11129418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgeon Quality Control and Standardization of D2 Lymphadenectomy for Gastric Cancer: A Prospective Multicenter Observational Study (KLASS-02-QC).
    Han SU; Hur H; Lee HJ; Cho GS; Kim MC; Park YK; Kim W; Hyung WJ;
    Ann Surg; 2021 Feb; 273(2):315-324. PubMed ID: 33064386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical selection and metastatic warning of splenic lymph node dissection in advanced gastric cancer radical surgery: a prospective, single-center, randomized controlled trial].
    Guo X; Bian SB; Peng Z; Wang N; Wei B; Cui JX; Wang XX; Xie TY; Xi HQ; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):144-151. PubMed ID: 32074794
    [No Abstract]   [Full Text] [Related]  

  • 9. Short-term surgical outcomes of a randomized controlled trial comparing laparoscopic versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer.
    Shi Y; Xu X; Zhao Y; Qian F; Tang B; Hao Y; Luo H; Chen J; Yu P
    Surg Endosc; 2018 May; 32(5):2427-2433. PubMed ID: 29234941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial).
    Haverkamp L; Brenkman HJ; Seesing MF; Gisbertz SS; van Berge Henegouwen MI; Luyer MD; Nieuwenhuijzen GA; Wijnhoven BP; van Lanschot JJ; de Steur WO; Hartgrink HH; Stoot JH; Hulsewé KW; Spillenaar Bilgen EJ; Rütter JE; Kouwenhoven EA; van Det MJ; van der Peet DL; Daams F; Draaisma WA; Broeders IA; van Stel HF; Lacle MM; Ruurda JP; van Hillegersberg R;
    BMC Cancer; 2015 Jul; 15():556. PubMed ID: 26219670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic Versus Open Gastrectomy for Gastric Cancer (LOGICA): A Multicenter Randomized Clinical Trial.
    van der Veen A; Brenkman HJF; Seesing MFJ; Haverkamp L; Luyer MDP; Nieuwenhuijzen GAP; Stoot JHMB; Tegels JJW; Wijnhoven BPL; Lagarde SM; de Steur WO; Hartgrink HH; Kouwenhoven EA; Wassenaar EB; Draaisma WA; Gisbertz SS; van der Peet DL; May AM; Ruurda JP; van Hillegersberg R;
    J Clin Oncol; 2021 Mar; 39(9):978-989. PubMed ID: 34581617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Comprehensive Complication Index versus Clavien-Dindo grading after laparoscopic and open D2-gastrectomy in the multicenter randomized LOGICA-trial.
    Triemstra L; de Jongh C; Tedone F; Brosens LAA; Luyer MDP; Stoot JHMB; Lagarde SM; van Hillegersberg R; Ruurda JP;
    Eur J Surg Oncol; 2023 Dec; 49(12):107095. PubMed ID: 37913608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short-term efficacy evaluation of laparoscopic spleen-preserving splenic hilus lymphadenectomy and left epigastrium mesogastric excision for advanced proximal gastric cancer based on mesangial anatomy].
    Zhang YF; Chen P; Sun JG; Fan XJ; Wang YM; Gao YS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):177-182. PubMed ID: 32074799
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase-II clinical trial of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for gastric cancer patients.
    Lee JH; Kim YW; Ryu KW; Lee JR; Kim CG; Choi IJ; Kook MC; Nam BH; Bae JM
    Ann Surg Oncol; 2007 Nov; 14(11):3148-53. PubMed ID: 17705092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Indocyanine Green Tracer-Guided Lymph Node Dissection During Laparoscopic Radical Gastrectomy in Patients With Gastric Cancer: A Randomized Clinical Trial.
    Chen QY; Xie JW; Zhong Q; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng HL; Li P; Zheng CH; Huang CM
    JAMA Surg; 2020 Apr; 155(4):300-311. PubMed ID: 32101269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance to D2 lymphadenectomy in laparoscopic gastrectomy.
    Eshuis WJ; van Berge Henegouwen MI; Draaisma WA; Gisbertz SS
    Updates Surg; 2018 Jun; 70(2):197-205. PubMed ID: 29926307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic total gastrectomy for upper-middle advanced gastric cancer: analysis based on lymph node noncompliance.
    Chen QY; Lin GT; Zhong Q; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Huang CM
    Gastric Cancer; 2020 Jan; 23(1):184-194. PubMed ID: 31300914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robotic distal subtotal gastrectomy with D2 lymphadenectomy for gastric cancer patients with high body mass index: comparison with conventional laparoscopic distal subtotal gastrectomy with D2 lymphadenectomy.
    Lee J; Kim YM; Woo Y; Obama K; Noh SH; Hyung WJ
    Surg Endosc; 2015 Nov; 29(11):3251-60. PubMed ID: 25631106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term oncologic outcomes of a randomized controlled trial comparing laparoscopic versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer.
    Shi Y; Xu X; Zhao Y; Qian F; Tang B; Hao Y; Luo H; Chen J; Yu P
    Surgery; 2019 Jun; 165(6):1211-1216. PubMed ID: 30772006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.